At the 2016 Association for Research in Vision and Ophthalmology (ARVO) meeting in Seattle, about 100 uveitis and uveitis-related papers and posters were presented by researchers from around the world. The presentations covered a wide range of research initiatives that are underway to treat–or at least understand how to address–uveitis. Here are five intriguing abstracts of research that were presented at the meeting.
In order to avoid a public health crisis and keep up with increasing vision loss among the aging baby-boomer generation, correctable vision impairments must be eliminated by 2030, according to a report issued by the National Academies of Sciences, Engineering, and Medicine (NASEM).
An increasing number of treatment options have given patients facing diabetic macular edema (DME) new hope in the face of this chronic, progressive, and blinding disease. Experience and time have shown us there is not a one-size-fits-all solution for patients with DME. To get the results we want, we need to screen our patients and match them with the treatment protocol best suited to their needs.
As a continuation of the VSP eye health index for 2016, here are the 10 least eye-healthy cities in the United States.
Ready for some big news? Johnson & Johnson announced they have entered into a definitive agreement to acquire Abbott Medical Optics (AMO) for $4.325 billion in cash. AMO’s business segments include cataract surgery, laser refractive surgery, and consumer eye health, and reported sales in 2015 were $1.1 billion.
When a three-piece IOL intended for sulcus placement dislocates posteriorly during an IOL exchange procedure, cataract surgeons can consider several possible strategies.
When it comes to their eyes, patients want the safest treatments, and they know the best technology available is a laser. The cataract patient demographic is changing, and patients today have active lifestyles that demand functional vision.
EyeGuru.org is an educational website designed by ophthalmology residents for ophthalmology residents. The website states upfront, “You get no more and no less information than exactly what's needed.”
Achieving spectacle independence for distance vision after toric IOL implantation depends on the refractive outcome. Factors affecting residual astigmatism and studies evaluating the use of various surgical techniques and technologies relating to those factors are discussed.
An updated classification of corneal dystrophies will help clinicians with properly differentiating and naming the disorders.
A surgeon with clinical experience with three femtosecond lasers discusses the practicalities of creating ideal femtosecond laser inlay pockets.
On the heels of the recent FDA approval of corneal collagen crosslinking, some surgical pearls are provided for the treatment of progressive keratoconus and corneal ectasia.
When Martin Luther King said, “I have a dream,” he had a vision for people, not a program. Visionary leaders have the ability to communicate values and ideas in a way that connects. In your practice, they bring certainty into the uncertain world of reimbursement rates and rapid change. What is your capacity to bring vision and direction into times of uncertainty?
Aflibercept remains superior to bevacizumab after 2 years of treating patients with poor baseline visual acuity (VA) caused by diabetic macular edema (DME), but it loses its edge over ranibizumab, researchers said.
Shub-ad loved ophthalmology, but was having trouble deciding on her subspecialty. She knew her wise chairman, Pay-Dro, would help her think through the options.
A preview of what to expect at AAO 2016 in Chicago!
A 6-month analysis from the REINFORCE study of the dexamethasone intravitreal implant Ozurdex found an average of one- to two-line vision gains and no new safety concerns.
Nepal’s Tilganga Institute of Ophthalmology has been working to build one of the most successful corneal donation programmes in the world.
Check out the latest results from the 2016 VSP Vision Care Eye Health Index!
Watch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.
The first implantable intraocular lens (IOL) was surgically inserted nearly 70 years ago by Sir Harold Ridley at St. Thomas Hospital in London. It took more than two decades for the use of polymethyl methacrylate (PMMA) IOLs to catch on, but by the 1970s, PMMA IOLs were routinely implanted after cataract surgery.
In the 1980s and 90s, a number of attempts to develop smaller-gauge, self-sealing vitrectomy procedures were initiated, but it took until 2002 for the movement to gain momentum when Dr. Gildo Fujii of the University of Southern California initially described his use of a sutureless, transconjunctival, 25-gauge (0.5 mm) PPV system in a variety of surgical cases.
I feel inspired to offer my own vision for the working future: the ten-day workweek for ophthalmologists.
Sleep position may be correlated with the severity of dry eye symptoms, suggests a new study.
Selective laser trabeculoplasty is a reasonable treatment option to reduce IOP in glaucoma patients who have had previous glaucoma surgery.
Refractive surgeons can consider fibrin adhesives to prevent the recurrence of epithelial ingrowth after LASIK.
A 110° reverse side cut primary incision created with a femtosecond laser provides an effective seal for potential wound leakage in a recent study.
An iPad-based quick contrast sensitivity test had similar sensitivity and specificity to frequency-doubling technology.
Multifocal IOLs offer the potential to reduce spectacle dependence, but outcomes vary depending on optical design. Optimizing success and satisfaction depends on careful patient selection, thorough counseling, and good surgical technique.